Iron Gate Global Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Iron Gate Global Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11,739	Closed	-$1.23M	–	75
2019 Q2	$1.23M	Sell	11,739 -352	-3%	-$37.4K	0.82%	24
2019 Q1	$1.35M	Sell	12,091 -258	-2%	-$28.3K	0.54%	24
2018 Q4	$1.19M	Sell	12,349 -354	-3%	-$37.6K	0.88%	21
2018 Q3	$1.55M	Sell	12,703 -575	-4%	-$67.7K	1.01%	20
2018 Q2	$1.46M	Sell	13,278 -591	-4%	-$63.2K	1.07%	20
2018 Q1	$1.48M	Buy	13,869 +3,355	+32%	+$372K	1.12%	22
2017 Q4	$1.12M	Sell	10,514 -49	-0.5%	-$5.24K	0.95%	21
2017 Q3	$1.18M	Buy	10,563 +7,101	+205%	+$759K	1.1%	21
2017 Q2	$358K	Buy	+3,462	New	+$341K	0.4%	30

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Iron Gate Global Advisors's IBB Position: Q3 2019 in Review

Iron Gate Global Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 11,739 shares — an estimated $1.23M sold.

Iron Gate Global Advisors first reported a position in IBB in Q2 2017 and held it in 9 quarters. The position peaked at $1.55M in Q3 2018. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Iron Gate Global Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Iron Gate Global Advisors sold 11,739 iShares Biotechnology ETF shares in Q3 2019, an estimated $1.23M.
Iron Gate Global Advisors first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 9 quarters.
Iron Gate Global Advisors's iShares Biotechnology ETF position peaked at $1.55M in Q3 2018.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Iron Gate Global Advisors's 13F filing for Q3 2019, filed 15 Nov 2019.